A Randomised Trial of Conformal versus Conventional Radiotherapy in Pelvic Neoplasms
ISRCTN | ISRCTN17264730 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN17264730 |
ClinicalTrials.gov number | NCT00867347 |
Secondary identifying numbers | ICR/PELVIC |
- Submission date
- 19/08/2002
- Registration date
- 19/08/2002
- Last edited
- 03/01/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr - -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | |
Study objectives | Not provided at time of registration |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cancer: Bladder (advanced), Bladder (superficial), Multiple Sites, Prostate, Rectum |
Intervention | 1. Group A: Conventional radiotherapy using a three field technique employing rectangular fields. Suggested dosage, 64 Gy in 2 Gy fractions five times a week 2. Group B: Conformal radiotherapy using a three field technique employing fields shaped with customised blocks drawn according to the beam's-eye view of the target volume. Suggested dosage, 64 Gy in 2 Gy fractions five times a week. |
Intervention type | Other |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/01/2001 |
Completion date | 31/12/2001 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | 1. Carcinoma of the pelvic region (eg prostate, bladder, rectum, etc) 2. Patients scheduled to undergo pelvic radiotherapy by a CT planned technique with less than four fields provided a satisfactory localisation on the simulator can be achieved |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/01/2001 |
Date of final enrolment | 31/12/2001 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
The Institute of Cancer Research (UK)
Government
Government
123 Old Brompton Road
London
SW7 3RP
United Kingdom
Website | http://www.icr.ac.uk |
---|---|
https://ror.org/043jzw605 |
Funders
Funder type
Research organisation
Institute of Cancer Research (UK)
Government organisation / National government
Government organisation / National government
- Alternative name(s)
- Institute of Cancer Research - CIHR, CIHR Institute of Cancer Research, L'Institut du cancer, Institut du cancer, ICR - CIHR, ICR, IC
- Location
- Canada
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/02/1997 | Yes | No |